All News

The dopamine agonists cabergoline and bromocriptine have replaced surgery for prolactinomas, a key cause of infertility. Two experts share their protocols for treating these benign tumors and explain which drug to choose when pregnancy is the goal--and which better restores menses.

Many women are more impaired by premenstrual symptoms such as depression, anxiety, mood swings, and anger than by physical changes. Lower and luteal-phase dosing with selective serotonin reuptake inhibitors is an effective treatment strategy.

Folic acid, calcium, and iron are essential not only during pregnancy but also for long-term health. But supplements may not meet all of a patient's nutritional needs.

Once a common cause of perinatal death, Rh disease is now quite rare in pregnant women, thanks in large part to advances in U/S and DNA technology. But the fact that roughly 7 out of every 1,000 liveborn infants are delivered by Rh-sensitized women emphasizes the need for more vigorous preventive efforts and up-to-date management skills.

Out of Israel come several potentially useful ob/gyn devices, the development of which is being sponsored in part by the government's Chief Scientist Office.

Relieving the pain of endometriosis requires visualization of "invisible" lesions and complete elimination of all implants. Blue light, pain mapping, and laser therapy hold promise in increasing the likelihood of success.

Two experts review the tension-free vaginal tape procedure that revolutionized SUI treatment, the wide choice of pubovaginal sling types now available, and the latest approach: transobturator slings.

An EMR program can streamline-or complicate-ob/gyn practice. Answering several critical questions before you choose a system can go a long way to ensuring a successful outcome.

There are several biological mechanisms behind the age-related drop in female fertility--and a number of tests to assess this decline.

Depression does occur in pregnant women and not just in those with preexisting mood symptoms. Knowing how to detect the disorder and when to refer is important because you may be the only physician these patients see during the perinatal period.

Measuring cervical length and funneling with transvaginal ultrasound can help ob/gyns predict which patients will deliver preterm. But how do you interpret U/S results and put them to use in patient care? An expert in the field offers practical guidelines for meeting this challenge.

Studies leave little doubt that this nonsteroidal anti-inflammatory agent can stop preterm labor. But the drug also needs to be administered wisely, and with several fetal complications in mind.

Both direct and indirect evidence support this hypothesis.

Case Studies in Coding--Practical advice on reimbursement.

When during the first trimester is it valuable to measure levels of this hormone and when is it a waste of time? Will giving your patients progesterone supplements help prevent miscarriage? Are they safe?

While insulin-sensitizing agents like metformin have proven useful in managing this disorder, mounting evidence indicates that rosiglitazone can also help induce ovulation and improve the metabolic profile in these patients.

Your patient has CIN, a precursor to cervical cancer. How do you manage her pregnancy? An expert pathologist provides algorithms and a step-by-step guide for safely biopsying a pregnant cervix-when appropriate.

Large studies do not support an association

Both direct and indirect evidence support this hypothesis.

This study was carried out to identify risk factors associated with urinary incontinence in women three months after giving birth.

Women need thorough and accurate information about the entire array of contraceptive options--new and old--so they can find their ideal method. Adherence--not efficacy--is the problem, and the hope is that greater choice will translate into fewer unintended pregnancies.